RecruitingNCT06096805

Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)

Sponsor

Shanghai First Maternity and Infant Hospital

Enrollment

2,000 participants

Start Date

Aug 10, 2023

Study Type

OBSERVATIONAL

Conditions

Fetal Growth Retardation

Summary

This study intends to prospectively enroll high-risk pregnant women to establish a multicenter cohort. By combining maternal basic characteristics, medical history, early pregnancy ultrasound, and biological markers, we aim to construct a joint predictive model for MVM-FGR.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with fetal growth retardation. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Shanghai First Maternity and Infant Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06096805

Related Trials

Investigating the Structured Use of Ultrasound Scanning for Fetal Growth

NCT036621781 location

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction

NCT0565134712 locations